Kun Deng1,2,3, Jianliang Huang1,2,3, Danyang Li2,3, Wei Gao2,3, Minghua Wu2,3,4,*, Mingsheng Lei1,5,*
Oncology Research, Vol.34, No.1, 2026, DOI:10.32604/or.2025.069442
- 30 December 2025
Abstract Background: Glioblastoma (GBM) prognosis has seen little improvement over the past two decades. While immunotherapy has revolutionized cancer treatment, its impact on GBM remains limited. To characterize the evolving research landscape and identify future directions in GBM immunotherapy, we conducted a comprehensive bibliometric review. Methods: All literature related to immunotherapy in GBM from 1999 to 2024 was collected from the Web of Science Core Collection. CtieSpace and VOSviewer were used to conduct bibliometric analysis and visualize the data. Results: Bibliometric analysis identified 5038 publications authored by 23,335 researchers from 4699 institutions across 96 countries/regions, published in… More >